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Background
HIV-1 requires the support of its appropriate host for the
survival and propagation like any other parasite. These
host cell factors have been reported to be involved in dif-
ferent stages of viral life cycle. The nuclear import and
infection maintenance of HIV-1 Integrase (IN) in human
cells is dependent upon the integration efficiency of the
proviral DNA and stability of viral RNA. In our study we
identified a new host cell interacting factor for HIV-1 IN,
SFPQ-a RNA splicing protein, by cross-linking, pull
down and mass spectrometry.
Methods
This study involved gene cloning, protein expression,
purification, cell culture, transfection and selection of
stable cell lines for the HIV-1 IN GFP fusion protein
and in-vitro IN activity assays study.
Results
We identified a new host cell interacting factor for HIV-
1 IN-SFPQ, an RNA splicing protein that interacts with
HIV-1, shows 5 fold binding (Kd 0.05 µM) and modu-
lates its disintegration activity.
Conclusions
This study presents SFPQ as a novel cellular factor
which has functional interaction with HIV-1 IN. SFPQ,
revealed that this protein is not only recruited to the
sites where viral genome integration takes place but also
increases the disintegration activity and 3’ end proces-
sing activities of HIV-1 IN.
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